Sign In
Last checked at 
10 Mar 2009 17:13
ο»Ώ
NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY OR CONNECTED PERSONS
This form is intended for use by anΒ issuerΒ to make aΒ RISΒ notification required byΒ DRΒ 3.1.4R(1).
Β
|
(1) |
AnΒ issuerΒ making a notification in respect of a transaction relating to theΒ sharesΒ or debentures of theΒ issuerΒ should complete boxes 1 to 16, 23 and 24. |
|
(2) |
AnΒ issuerΒ making a notification in respect of a derivative relatingΒ toΒ theΒ sharesΒ of theΒ issuerΒ should complete boxes 1 to 4, 6, 8,Β 13, 14, 16, 23 and 24.Β |
|
(3) |
AnΒ issuerΒ making a notification in respect of options granted to aΒ director/person discharging managerial responsibilitiesΒ should complete boxes 1 to 3 and 17 to 24.Β |
|
(4) |
AnΒ issuerΒ making a notification in respect of aΒ financial instrumentΒ relating to theΒ sharesΒ of theΒ issuerΒ (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.Β |
Β
Please complete all relevant boxes in block capital letters.
1.Β Name of theΒ issuer
PHYTOPHARM PLC
2.Β State whether the notification relates to (i) a transaction notified in accordance withΒ DRΒ 3.1.4R(1)(a); orΒ (ii)Β DRΒ 3.1.4(R)(1)(b) a disclosure made in accordance with section 324 (as extended by section 328) of the Companies Act 1985; or (iii) both (i) and (ii)
(III) BOTHΒ (I)Β AND (II)
3.Β Name ofΒ person discharging managerial responsibilities/director
MR ALEXANDER DUNBAR MORRISON, ACTING CHIEF EXECUTIVE
4.Β State whether notification relates to aΒ personΒ connected with aΒ person discharging managerial responsibilities/directorΒ named in 3 and identify theΒ connected person
AS 3 ABOVE
5.Β Indicate whether the notification is in respect of a holding of theΒ personΒ referred to in 3 or 4 above or in respect of a non-beneficial interest
AS 3 ABOVE
6.Β Description ofΒ sharesΒ (includingΒ class), debentures or derivatives or financial instruments relating toΒ shares
ORDINARY SHARES OF 1 PENCE EACH
7.Β Name of registered shareholders(s) and, if more than one, the number ofΒ sharesΒ held by each of them
AS 3 ABOVE
8Β State the nature of the transaction
SHARES ACQUIRED
9.Β Number ofΒ shares, debentures or financial instruments relating toΒ sharesΒ acquired
66,750
10.Β Percentage of issuedΒ classΒ acquired (treasury sharesΒ of thatΒ classΒ should not be taken into account when calculating percentage)
0.07%
11.Β Number ofΒ shares, debentures or financial instruments relating toΒ sharesΒ disposed
12.Β Percentage of issuedΒ classΒ disposed (treasury sharesΒ of thatΒ classΒ should not be taken into account when calculating percentage)Β
13.Β Price perΒ shareΒ or value of transaction
4.5Β PENCE PER SHARE
14.Β Date and place of transaction
10 March 2009, LONDON
15.Β Total holding following notification and total percentage holding following notification (anyΒ treasury sharesΒ should not be taken into account when calculating percentage)
96,544 - 0.10%
16.Β Date issuer informed of transaction
10 MARCH 2009
If aΒ person discharging managerial responsibilitiesΒ has been granted options by theΒ issuerΒ complete the following boxes
17Β Date of grant
18.Β Period during which or date on which it can be exercised
19.Β Total amount paid (if any) for grant of the option
20.Β Description ofΒ sharesΒ or debentures involved (classΒ and number)
21.Β Exercise price (if fixed at time of grant) or indication that price is to be fixed at the time of exercise
22.Β Total number ofΒ sharesΒ or debentures over which options held following notification
23.Β Any additional information
24.Β Name of contact and telephone number for queries
ZOE MCGOWAN 01480 437697
Name and signature of duly authorised officer ofΒ issuerΒ responsible for making notification
ZOE MCGOWAN
Date of notification
10 MARCH 2009
ENDΒ
Follow the stocks
